These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 35545342

  • 1. Changes of new coagulation markers in healthy pregnant women and establishment of reference intervals in Changsha.
    Yang Y, Hu Y, Wu M, Xiang Z.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr 28; 47(4):469-478. PubMed ID: 35545342
    [Abstract] [Full Text] [Related]

  • 2. Trimester-specific reference intervals of TAT, TM, tPAI-C and PIC for healthy Chinese pregnant women.
    Wu Y, Qiao Y, Zhang Y, Li Q, Zhang W.
    J Obstet Gynaecol Res; 2021 Jan 28; 47(1):368-374. PubMed ID: 33345424
    [Abstract] [Full Text] [Related]

  • 3. Trimester-specific reference intervals of hemostasis biomarkers for healthy pregnancy.
    Xiao H, Yu W, Li L, Yin X, Zhai Q, Hu D, Zhang X, Wang F.
    Scand J Clin Lab Invest; 2023 Oct 28; 83(6):379-383. PubMed ID: 37491076
    [Abstract] [Full Text] [Related]

  • 4. Coagulation and Fibrinolysis Biomarkers as Potential Indicators for the Diagnosis and Classification of Ovarian Hyperstimulation Syndrome.
    Li S, Qian Y, Pei Y, Wu K, Lu S.
    Front Med (Lausanne); 2021 Oct 28; 8():720342. PubMed ID: 34513881
    [Abstract] [Full Text] [Related]

  • 5. A single-center study of reference intervals for TAT, PIC, TM and t-PAIC in healthy older Chinese adults.
    Zhang L, Chen Y, Hu R, Chen H, Peng X, Yuan H.
    Thromb J; 2024 Sep 19; 22(1):82. PubMed ID: 39300541
    [Abstract] [Full Text] [Related]

  • 6. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
    Mutoh S, Kobayashi M, Hirata J, Itoh N, Maki M, Komatsu Y, Yoshida A, Sasa H, Kuroda K, Kikuchi Y.
    Agents Actions Suppl; 1992 Sep 19; 38 ( Pt 2)():320-9. PubMed ID: 1462839
    [Abstract] [Full Text] [Related]

  • 7. Performance evaluation of thrombomodulin, thrombin-antithrombin complex, plasmin-α2-antiplasmin complex, and t-PA: PAI-1 complex.
    Chen Q, Shou W, Wu W, Wang G, Cui W.
    J Clin Lab Anal; 2019 Jul 19; 33(6):e22913. PubMed ID: 31090232
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.
    Zhou K, Zhang J, Zheng ZR, Zhou YZ, Zhou X, Wang LD, Suo B, Jiang XF, Liu PJ, Wang DH.
    Clin Appl Thromb Hemost; 2020 Jul 19; 26():1076029620971041. PubMed ID: 33141604
    [Abstract] [Full Text] [Related]

  • 9. Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-α2-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study.
    Wang L, Zhong J, Xiao D, Huang W, Zheng Z, Jiang Y.
    Ann Transl Med; 2022 Dec 19; 10(23):1273. PubMed ID: 36618792
    [Abstract] [Full Text] [Related]

  • 10. Performance evaluation of thrombus molecular markers thrombomodulin, thrombin-antithrombin complex, plasmin-α2-plasmin inhibitor complex, and tissue plasminogen activator-inhibitor complex by a chemiluminescence analyzer.
    Lirong T, Minmin X, Manqiu Y, Yanping L.
    Hippokratia; 2022 Dec 19; 26(2):78-82. PubMed ID: 37188051
    [Abstract] [Full Text] [Related]

  • 11. The clinical significance of TAT, PIC, TM, and t-PAIC in vascular events of BCR/ABL-negative myeloproliferative neoplasms.
    Huang K, Mo Q, Liao C, Feng S, Liu G, Jiang D, Lei P.
    Clin Exp Med; 2024 May 22; 24(1):107. PubMed ID: 38776019
    [Abstract] [Full Text] [Related]

  • 12. Changes of serum homocysteine levels during pregnancy and the establishment of reference intervals in pregnant Chinese women.
    Yang Y, Jiang H, Tang A, Xiang Z.
    Clin Chim Acta; 2019 Feb 22; 489():1-4. PubMed ID: 30468714
    [Abstract] [Full Text] [Related]

  • 13. Changes in Coagulation and Fibrinolysis in Post-Cesarean Section Parturients Treated With Low Molecular Weight Heparin.
    Liu Z, Liu C, Zhong M, Yang F, Chen H, Kong W, Lv P, Chen W, Yao Y, Cao Q, Zhou H.
    Clin Appl Thromb Hemost; 2020 Feb 22; 26():1076029620978809. PubMed ID: 33296256
    [Abstract] [Full Text] [Related]

  • 14. A performance evaluation of chemiluminescence enzyme immunoassays on the Sysmex CN-6500 haemostasis analyser.
    Gardiner C, Lane P, Tailor H, Machin SJ, Mackie IJ.
    Int J Lab Hematol; 2021 Dec 22; 43(6):1593-1598. PubMed ID: 34252265
    [Abstract] [Full Text] [Related]

  • 15. [Predictive value of four items of new thrombus markers combined with conventional coagulation tests for thrombosis in antiphospholipid syndrome].
    Hong LR, Chen YJ, Jiang QL, Jia RL, Li C, Feng LH.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec 18; 55(6):1033-1038. PubMed ID: 38101785
    [Abstract] [Full Text] [Related]

  • 16. Changes of serum interleukin-6 in healthy pregnant women and establishment of relevant reference intervals.
    Fu Y, Tang L, Hu M, Xiang Z, Hu Y.
    Clin Chim Acta; 2020 Mar 18; 502():116-119. PubMed ID: 31866334
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic value of plasmin-α2-plasmin inhibitor complex in patients with malignant tumor and venous thromboembolism.
    Liu J, Wang F, Wang Y, He SS, Wang YY, Wei LH.
    Hippokratia; 2023 Mar 18; 27(2):37-40. PubMed ID: 39056098
    [Abstract] [Full Text] [Related]

  • 18. Serum prolactin levels across pregnancy and the establishment of reference intervals.
    Hu Y, Ding Y, Yang M, Xiang Z.
    Clin Chem Lab Med; 2018 Apr 25; 56(5):838-842. PubMed ID: 29194037
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of Coagulation, Fibrinolysis and Endothelial Biomarkers in Cirrhotic Patients With or Without Portal Venous Thrombosis.
    Ren W, Zhang J, Chen Y, Wen M, Su Y, Zhao Y, Lu S, Wu J.
    Clin Appl Thromb Hemost; 2020 Apr 25; 26():1076029620982666. PubMed ID: 33356499
    [Abstract] [Full Text] [Related]

  • 20. Automated measurement of coagulation and fibrinolytic activation markers: Outcomes in coronavirus disease 2019 (COVID-19) patients.
    Gardiner C, Mackie IJ, MacCallum P, Platton S.
    Int J Lab Hematol; 2022 Oct 25; 44(5):817-822. PubMed ID: 35451557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.